Hallucinogens fall into several different classes, as broadly defined by pharmacological
mechanism of action, and chemical structure. These include psychedelics, entactogens …

In vitro human studies show that the metabolism of most amphetamine-like psychostimulants
is regulated by the polymorphic cytochrome P450 isozyme CYP2D6. Two compounds …

Written for practitioners in the field, this critically acclaimed bestseller provides authoritative
information focused on the investigation of drug-related deaths and practical approaches to …

The potentially serious outcomes from ingestion of and dependence on toxins make this an
important topic for epileptologists. We must be aware of the potential for harm from …

Aim of the study was to analyze temporal trends in prevalence of hyponatremia over four
decades in different settings. A systematic review of the literature from 1966 to 2009 yielded …

The use of carbamazepine (CBZ) and oxcarbazepine (OXC) as first‐line antiepileptic drugs
in the treatment of focal epilepsy is limited by hyponatremia, a known adverse effect …

Background Previous research in animals and humans has demonstrated a potential role of
stress regulatory systems, such as the hypothalamic-pituitary-adrenal (HPA) axis and the …

The synthetic psychostimulant MDMA (±3, 4-methylenedioxymethamphetamine, ecstasy)
acts as an indirect serotonin, dopamine, and norepinephrine agonist and as a mechanism …

The illicit drug 3, 4-methylenedioxymethamphetamine (MDMA) has profound physiological
cerebral, cardiac, and hepatic effects that are reflected in the blood. Screening of blood for …

Clinical outcome following 3, 4-methylenedioxymethamphetamine (MDMA) intake ranges
from mild entactogenic effects to a life-threatening intoxication. Despite ongoing research …